Sarah J. Danson
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 55
- CAR-T cell therapy research 15
- Cancer Immunotherapy and Biomarkers 15
- Lung Cancer Research Studies 10
-
- Cancer Genomics and Diagnostics 17
- Co-authors
- Malcolm Ranson (15 shared papers)Martin Peter Zeidler (4 shared papers)Sally J. Thomas (4 shared papers)John Andrew Snowden (4 shared papers)Mark J. Clemons (2 shared papers)Anthony Howell (2 shared papers)Mark Ross Middleton (10 shared papers)Timothy H. Ward (3 shared papers)
- Journals
- Annals of Oncology (18 papers)Lung Cancer (10 papers)Nature (7 papers)Journal of Thoracic Oncology (6 papers)European Journal of Cancer (5 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Sarah J. Danson
131 papers receiving 8.8k citations
Sarah J. Danson's Hit Papers
Peers
Comparison fields: 5 of 150
- Oncology 3.6k
- Immunology 1.9k
- Cancer Research 1.3k
- Pulmonary and Respiratory Medicine 1.8k
- Molecular Biology 2.4k
Countries citing papers authored by Sarah J. Danson
This map shows the geographic impact of Sarah J. Danson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah J. Danson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah J. Danson more than expected).
Fields of papers citing papers by Sarah J. Danson
This network shows the impact of papers produced by Sarah J. Danson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah J. Danson. The network helps show where Sarah J. Danson may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarah J. Danson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 140 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution Hit paper breakdown → | 2017 | 1015 |
| 2 | Lung adenocarcinoma promotion by air pollutants Hit paper breakdown → | 2023 | 528 |
| 3 | Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies Hit paper breakdown → | 2018 | 509 |
| 4 | The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours Hit paper breakdown → | 2015 | 489 |
| 5 | Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy Hit paper breakdown → | 2015 | 432 |
| 6 | 2017 | 369 | |
| 7 | 2004 | 345 | |
| 8 | 2004 | 329 | |
| 9 | Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA Hit paper breakdown → | 2023 | 255 |
| 10 | 2004 | 232 | |
| 11 | 2002 | 201 | |
| 12 | Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial Hit paper breakdown → | 2021 | 195 |
| 13 | The evolution of lung cancer and impact of subclonal selection in TRACERx Hit paper breakdown → | 2023 | 188 |
| 14 | 2020 | 187 | |
| 15 | 2004 | 168 | |
| 16 | The evolution of non-small cell lung cancer metastases in TRACERx Hit paper breakdown → | 2023 | 154 |
| 17 | 2023 | 138 | |
| 18 | 2015 | 135 | |
| 19 | 2016 | 101 | |
| 20 | 2010 | 98 |
About Sarah J. Danson
Sarah J. Danson is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Molecular Biology, having authored 140 papers that have together received 8.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Cancer Genomics and Diagnostics (17 papers), CAR-T cell therapy research (15 papers), Cancer Immunotherapy and Biomarkers (15 papers), Lung Cancer Research Studies (10 papers), Immunotherapy and Immune Responses (10 papers), Melanoma and MAPK Pathways (8 papers) and Occupational and environmental lung diseases (7 papers). The work is most often cited by research in Oncology (3.6k citations), Immunology (1.9k citations), Cancer Research (1.3k citations), Pulmonary and Respiratory Medicine (1.8k citations) and Molecular Biology (2.4k citations). Sarah J. Danson has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Malcolm Ranson, Martin Peter Zeidler, Sally J. Thomas, John Andrew Snowden, Mark J. Clemons, Anthony Howell, Mark Ross Middleton, Timothy H. Ward, Paul C Lorigan and Andrew R. Clamp. Their work appears in journals such as Annals of Oncology, Lung Cancer, Nature, Journal of Thoracic Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.